These GAIN Enhancer‐associated genes were significantly enriched in multiple HNSCC‐associated pathways including PI3K‐AKT, MAPK signaling, and transcriptional misregulation in cancer, and others (Figure 1H). This evidence concerns the gene AKT1 and cancer.